Q2 saw strong organic growth, margin expansion, and double-digit adjusted EPS growth, driven by robust demand in automation and successful execution of the Aerospace spin-off. Full-year guidance was raised for sales, margins, and adjusted EPS, reflecting confidence in continued profitable growth.Or…
Q4 FY2026 net income rose 28.5% year-over-year to $20.3 million, with EPS up 31.7% and strong loan and deposit growth. Asset quality remained stable, efficiency improved, and the dividend was raised 8%.Original document: Southern Missouri Bancorp, Inc. [SMBC] SEC 8-K Current Report — Jul. 23 2026Th…
Net income rose 37% year-over-year to $1.59 billion for the first half of 2026, with operating revenues up 8% to $12.78 billion. Wildfire-related liabilities remain significant, but regulatory cost recovery and new debt issuances have strengthened liquidity and capital resources.Original document…
Q2 2026 net income rose to $18.8 million ($0.90/share), with strong loan and deposit growth, higher net interest margin, and improved capital ratios. Acquisition of HCB Financial Corp. completed, and integration is underway. Regulatory capital remains well above required levels.Original document: I…
Revenue grew 10% year-over-year to $11.99B in Q2 2026, with 5% organic growth and strong performance across all segments. Adjusted EPS rose 13% to $6.03, and the company repurchased $1.0B in stock while launching new products and expanding strategic collaborations.Original document: Thermo Fisher S…
Q2 2026 saw revenues rise to $5.2 billion and adjusted EBITDA triple sequentially, with a return to positive free cash flow and debt reduction. Strong domestic demand, especially in automotive, and improved Canadian market outlook support guidance for record second-half earnings and a leverage targ…
Q2 2026 saw double-digit revenue and high-teens EPS growth, led by strong Americas performance and margin expansion. Full-year 2026 outlook for revenue and adjusted EPS was raised, with continued robust demand in the Americas and weaker trends in Europe.Original document: Allegion plc [ALLE] SEC 8…
Q2 2026 saw $5.2B in revenue and $286M in Adjusted EBITDA, with strong liquidity and a clear path to leverage targets. Automotive volumes and prices rose, while asset sales and a $400M government contract supported debt reduction and future growth.Original document: Cleveland-Cliffs Inc. [CLF] Slid…
Q2 2026 saw net income rise to $34.2 million and EPS to $1.06, driven by strong loan growth and improved net interest margin. The quarter included a merger announcement with First Hawaiian Bank and disciplined expense management, despite higher merger-related costs.Original document: TriCo Bancshar…
Record quarterly revenue and strong automotive growth led to raised 2026 guidance for revenue, EBITDA, and free cash flow. A new $400M stock repurchase program was authorized, and the medical portfolio expanded via acquisition. Net leverage remains low and liquidity strong.Original document: Genthe…
GAAP and non-GAAP core EPS rose year-over-year, with strong operational progress in wildfire prevention and emissions reduction. Full-year 2026 non-GAAP core EPS guidance is reaffirmed, and $4.4 billion in utility debt financings were completed.Original document: Pacific Gas & Electric Co. [PCG] SE…
RNS Number : 6076N Poolbeg Pharma PLC 23 July 2026 TR-1: Standard form for notification of major holdingsThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United…
Comcast Corporation (NASDAQ: CMCSA) announced that its Board of Directors declared a quarterly cash dividend of $0.33 a share on the company’s common stock. The quarterly dividend is payable on October 28, 2026, to shareholders of record as of the close of business on October 7, 2026.To automatical…
Q2 2026 saw net sales rise 13.8% to $872.3M and adjusted EPS jump 28.8% to $2.37, driven by strong growth in high-value biologics and GLP-1 products. Guidance for 2026 projects 10–11% organic revenue growth and adjusted EPS of $8.85–$9.05.Original document: West Pharmaceutical Services, Inc. [WST…
RNS Number : 6072N Banco Santander S.A. 23 July 2026 Banco Santander, S.A. (the "Bank" or "Banco Santander"), in compliance with the Securities Market legislation, hereby communicates the following:OTHER RELEVANT INFORMATIONReference is made to our notice of inside information of 4 February 202…
RNS Number : 6062N Cambridge Cognition Holdings PLC 23 July 2026 TR-1: Standard form for notification of major holdings1. Issuer DetailsISINGB00B8DV9647Issuer NameCAMBRIDGE COGNITION HOLDINGS PLCUK or Non-UK IssuerUK2. Reason for NotificationAn acquisition or disposal of voting rights3. Details…
RNS Number : 6073N SIH Partners LLLP 23 July 2026 FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING T…
Order intake and sales grew strongly in H1 2026, led by defense and space, with robust profitability and exceptional free cash flow. Upgraded guidance reflects confidence in continued growth, especially in defense, while digital and payment services face market headwinds.Based on Thales SA [HO] Q2…
Net sales rose 3.4% year-over-year in Q2'26, with EBITDA up 11% and margin expansion. Net losses were driven by higher finance costs and FX volatility, especially in Argentina, while Mexico and the US delivered strong operational performance.Original document: Grupo Rotoplas SAB de CV [AGUA] Earnin…
Revenue and net income declined 18% and 14% year-over-year in H1 2026 due to lower fuel sales, though Q2 saw sequential improvement. Four new stations are planned for H2, CapEx is projected at QAR 200–300 million, and dividend declaration is deferred amid ongoing uncertainties.Based on Qatar Fuel-W…
